Concepedia

Félix Calderón

FC

Statistics

Publications

20

Citations

645

H-Index

15

Active since

2007

Affiliations

GlaxoSmithKline (Spain)(Current)

Medicines for Malaria Venture

GlaxoSmithKline (France)

GlaxoSmithKline (United States)

University of California San Diego

Félix Calderón is an author at GlaxoSmithKline (Spain) specializing in drug discovery, medicinal chemistry, and pharmacology.

ORCID

Publications per year

2007–2023

20

Publications

20

A high throughput screen for next-generation leads targeting malaria parasite transmission

Michael J. Delves, Celia Miguel-Blanco, Holly Matthews et al. · Nature Communications · 2018 · 109 citations · Full text

, , +14

Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos Arylpyrroles

Alice Williamson, Paul M. Ylioja, Murray N. Robertson et al. · ACS Central Science · 2016 · 105 citations · Full text

, , +15

An Invitation to Open Innovation in Malaria Drug Discovery: 47 Quality Starting Points from the TCAMS

Félix Calderón, David Barros, José M. Bueno et al. · ACS Medicinal Chemistry Letters · 2011 · 78 citations · Full text

, , +17

CODES, a novel procedure for ligand-based virtual screening: PDE7 inhibitors as an application example

Ana Castro, María José Jerez, Carmen Gil et al. · European Journal of Medicinal Chemistry · 2007 · 35 citations · Full text

, , +16

A New In Vivo Screening Paradigm to Accelerate Antimalarial Drug Discovery

Marı́a Belén Jiménez-Dı́az, Sara Viera, Javier Ibáñez et al. · PLoS ONE · 2013 · 33 citations · Full text

, , +17

1–5 of 20